Beckman Coulter Focusing on Molecular Dx, Tuck-in Acquisitions Post-Restructuring | GenomeWeb
Outside of its traditional lab-automation and clinical-diagnostics products, Beckman Coulter is focusing its efforts in the life sciences field on developing its next-generation molecular diagnostics platform, and a company official said this week that the firm will stick to tuck-in acquisitions.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.